| Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma A Mackay, A Burford, D Carvalho, E Izquierdo, J Fazal-Salom, KR Taylor, ... Cancer cell 32 (4), 520-537. e5, 2017 | 945 | 2017 |
| MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism P Bandopadhayay, LA Ramkissoon, P Jain, G Bergthold, J Wala, R Zeid, ... Nature genetics 48 (3), 273-282, 2016 | 293 | 2016 |
| Strain background influences neurotoxicity and behavioral abnormalities in mice expressing the tetracycline transactivator HJ Han, CC Allen, CM Buchovecky, MJ Yetman, HA Born, MA Marin, ... Journal of Neuroscience 32 (31), 10574-10586, 2012 | 100 | 2012 |
| CRAF gene fusions in pediatric low-grade gliomas define a distinct drug response based on dimerization profiles P Jain, TM Fierst, HJ Han, TE Smith, A Vakil, PB Storm, AC Resnick, ... Oncogene 36 (45), 6348-6358, 2017 | 76 | 2017 |
| Overcoming resistance to single-agent therapy for oncogenic BRAF gene fusions via combinatorial targeting of MAPK and PI3K/mTOR signaling pathways P Jain, A Silva, HJ Han, SS Lang, Y Zhu, K Boucher, TE Smith, A Vakil, ... Oncotarget 8 (49), 84697, 2017 | 49 | 2017 |
| Shared ACVR1 mutations in FOP and DIPG: opportunities and challenges in extending biological and clinical implications across rare diseases HJ Han, P Jain, AC Resnick Bone 109, 91-100, 2018 | 37 | 2018 |
| Dramatic response to combination pembrolizumab and radiation in metastatic castration resistant prostate cancer HJ Han, YR Li, M Roach III, R Aggarwal Therapeutic Advances in Medical Oncology 12, 1758835920936084, 2020 | 20 | 2020 |
| Discovery and functional characterization of the oncogenicity and targetability of a novel NOTCH1–ROS1 gene fusion in pediatric angiosarcoma P Jain, S Iyer, J Straka, LF Surrey, J Pogoriler, H Han, T Smith, C Busch, ... Molecular Case Studies 8 (6), a006222, 2022 | 8 | 2022 |
| Delivering Palliative Care to Hospitalized Oncology Patients: A Scoping Review HJ Han, JC Yeh, M McNichol, MK Buss Journal of Pain and Symptom Management, 2022 | 4 | 2022 |
| Are opioid infusions used inappropriately at end of life? Results from a quality/safety project JC Yeh, SG Chae, PJ Kennedy, C Lien, PW Malecha, HJ Han, MK Buss, ... Journal of Pain and Symptom Management 64 (3), e133-e138, 2022 | 3 | 2022 |
| Ion channel blockers and glioblastoma risk and outcome: a nested case–control and retrospective cohort studies B Boursi, HJ Han, K Haynes, R Mamtani, YX Yang Pharmacoepidemiology and drug safety 25 (10), 1179-1185, 2016 | 2 | 2016 |
| Outpatient Training During Hospice and Palliative Medicine Fellowship: A National Survey HJ Han, MC Ouellette, JC Yeh, LE Dodge, E Finlay, AM Cullinan, ... Journal of Pain and Symptom Management 68 (4), 340-351, 2024 | | 2024 |
| Palliative Medicine Fellows’ Discussions, Perceptions, and Training Regarding Medical Cannabis DR Sherry, R Patell, HJ Han, LE Dodge, IM Braun, MK Buss Journal of Pain and Symptom Management 67 (6), 471-477. e6, 2024 | | 2024 |
| Integrating palliative care into the evolving landscape of oncology HJ Han, CR Pilgrim, MK Buss Current Problems in Cancer, 101013, 2023 | | 2023 |
| An Elusive Seizure HJ Han, AL Parks, MP Shah, G Hsu, L Santhosh The Neurohospitalist 12 (1), 188-194, 2022 | | 2022 |
Adam ResnickChildren's Hospital of Philadelphia在 email.chop.edu 的电子邮件经过验证
Adam ResnickChildren's Hospital of Philadelphia在 email.chop.edu 的电子邮件经过验证
Payal JainSenior Translational Scientist, Servier Pharmaceuticals在 servier.com 的电子邮件经过验证